Safety, Tolerability and Pharmacokinetics of Single-Dose Oral SYHA1402 in Healthy Chinese Subjects

被引：0
|
作者：
Beibei Liang
Jin Wang
Guanxuanzi Zhang
Rui Wang
Yun Cai
机构：
[1] PLA General Hospital,Center of Medicine Clinical Research, Department of Pharmacy, Medical Supplies Center of Chinese
来源：
Neurology and Therapy | 2023年 / 12卷
关键词：
Aldose reductase inhibitor; Diabetic peripheral neuropathy; Pharmacokinetics; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：947 / 959
页数：12
相关论文
共 50 条
  • [1] Safety, Tolerability and Pharmacokinetics of Single-Dose Oral SYHA1402 in Healthy Chinese Subjects
    Liang, Beibei
    Wang, Jin
    Zhang, Guanxuanzi
    Wang, Rui
    Cai, Yun
    NEUROLOGY AND THERAPY, 2023, 12 (03) : 947 - 959
  • [2] Pharmacokinetics, Pharmacodynamics, and Safety of Single-Dose Canagliflozin in Healthy Chinese Subjects
    Chen, Xia
    Hu, Pei
    Vaccaro, Nicole
    Polidori, David
    Curtin, Christopher R.
    Stieltjes, Hans
    Sha, Sue
    Weiner, Sveta
    Devineni, Damayanthi
    CLINICAL THERAPEUTICS, 2015, 37 (07) : 1483 - 1492
  • [3] Effect of Food on the Single-Dose Pharmacokinetics and Safety of Ulipristal Acetate in Healthy Chinese Subjects
    Wang, Yilin
    Li, Yanru
    Peng, Chun
    Tang, Ling
    Wang, Yan
    LATIN AMERICAN JOURNAL OF PHARMACY, 2021, 40 (03): : 542 - 545
  • [4] Single-dose and multiple-dose pharmacokinetics and safety of telbivudine after oral administration in healthy Chinese subjects
    Hu, Pei
    Jiang, Ji
    Wang, Hongyun
    Pietropaolo, Keith
    Chao, George C.
    Brown, Nathaniel A.
    Zhou, Xiao-Jian
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (09) : 999 - 1007
  • [5] Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous (ZTI-01) and Oral Fosfomycin in Healthy Volunteers
    Wenzler, E.
    Ellis-Grosse, E. J.
    Rodvold, K. A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (09)
  • [6] Pharmacokinetics, safety, and tolerability of sulcardine sulfate: an open-label, single-dose, randomized study in healthy Chinese subjects
    Chen, Qian
    Qian, Hong-jie
    Wang, Wei
    Zhang, Meng-qi
    Lu, Dong-ying
    Lu, Chuan
    Jin, Jie-mei
    Hu, Chao-ying
    Liu, Gang-yi
    Jia, Jing-ying
    Zheng, Hong-chao
    Li, Xue-ning
    Yu, Chen
    Wang, Yi-ping
    Liu, Yun
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 (01) : 120 - 125
  • [7] Effect of Rifampin on the Single-Dose Pharmacokinetics of Oral Cabotegravir in Healthy Subjects
    Ford, S. L.
    Sutton, K.
    Lou, Y.
    Zhang, Z.
    Tenorio, A.
    Trezza, C.
    Patel, P.
    Spreen, W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (10)
  • [8] Single-Dose Pharmacokinetics, Safety, and Tolerability of Modified-Release Formulations of Lersivirine in Healthy Subjects
    Vourvahis, Manoli
    Wang, Ronnie
    da Costa, Laure Mendes
    Wang, Cunshan
    Weatherley, Barry
    Mukwaya, Geoffrey
    Tawadrous, Margaret
    Heera, Jayvant
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2014, 3 (06): : 472 - 476
  • [9] Single-dose pharmacokinetics of levetiracetam in healthy Chinese male subjects
    Zhao, Qian
    Jiang, Ji
    Li, XiaoMing
    Lu, Zhihong
    Hu, Pei
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (05) : 614 - 617
  • [10] Single-dose pharmacokinetics and safety of iptakalim hydrochloride in Chinese healthy volunteers
    Cai, Yun
    Chai, Dong
    Pei, Fei
    Fang, Yi
    Wang, Rui
    Liang, Bei-bei
    Cui, Wen-yu
    Bao, Cun-gang
    Wang, Hai
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2012, 64 (03) : 337 - 343
12345